Addus HomeCare (NASDAQ:ADUS) Receives “Market Outperform” Rating from JMP Securities

JMP Securities reaffirmed their market outperform rating on shares of Addus HomeCare (NASDAQ:ADUS) in a report published on Tuesday,Benzinga reports. JMP Securities currently has a $150.00 price target on the stock.

ADUS has been the subject of several other reports. Oppenheimer upped their target price on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Stephens reaffirmed an “overweight” rating and set a $142.00 price objective on shares of Addus HomeCare in a report on Wednesday, March 12th. StockNews.com cut shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Wednesday, February 26th. Finally, Macquarie reiterated an “outperform” rating and issued a $129.00 price objective on shares of Addus HomeCare in a report on Thursday, February 27th. One equities research analyst has rated the stock with a hold rating, seven have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $139.00.

Addus HomeCare Trading Up 0.7 %

Addus HomeCare stock opened at $99.54 on Tuesday. The stock’s 50 day simple moving average is $98.20 and its two-hundred day simple moving average is $116.35. Addus HomeCare has a 12 month low of $88.96 and a 12 month high of $136.72. The firm has a market cap of $1.81 billion, a PE ratio of 22.78, a P/E/G ratio of 1.41 and a beta of 0.93.

Addus HomeCare (NASDAQ:ADUS) last posted its earnings results on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.35 by ($0.09). Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm had revenue of $297.14 million for the quarter, compared to analysts’ expectations of $291.04 million. On average, equities research analysts forecast that Addus HomeCare will post 4.59 EPS for the current year.

Hedge Funds Weigh In On Addus HomeCare

A number of institutional investors have recently added to or reduced their stakes in ADUS. Dimensional Fund Advisors LP increased its stake in shares of Addus HomeCare by 1.5% in the 4th quarter. Dimensional Fund Advisors LP now owns 692,713 shares of the company’s stock worth $86,833,000 after acquiring an additional 10,434 shares during the last quarter. Principal Financial Group Inc. grew its stake in shares of Addus HomeCare by 17.5% in the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock valued at $67,293,000 after buying an additional 75,409 shares during the period. Capital Research Global Investors acquired a new stake in shares of Addus HomeCare during the 4th quarter worth approximately $51,149,000. TimesSquare Capital Management LLC raised its position in shares of Addus HomeCare by 28.5% during the 4th quarter. TimesSquare Capital Management LLC now owns 355,750 shares of the company’s stock valued at $44,593,000 after buying an additional 78,835 shares during the period. Finally, Invesco Ltd. grew its position in Addus HomeCare by 6.5% in the fourth quarter. Invesco Ltd. now owns 346,120 shares of the company’s stock worth $43,386,000 after acquiring an additional 21,266 shares during the period. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.